Pulsatile Administration of the Epidermal Growth Factor Receptor Inhibitor Gefitinib Is... - 0 views
-
Matthew Links on 11 Jul 1010.1158/1078-0432.CCR-04-1347
http://www.nature.com/nrc/archive/index.html - Database Access - UNSW Library - 0 views
-
figure of both direct and indirect hypothesis for antiangiogenic effects
Thrombospondin-1 Associated with Tumor Microenvironment Contributes to Low-Dose Cycloph... - 0 views
-
pivotal study in secondary hypothesis of angiogenesis
Inhibition of NF-{kappa}B sensitizes non-small cell lung cancer cells to chemotherapy-i... - 0 views
-
this paper highlights the role of NF-kappa in cell survival after gem it fits into the signalling survival versus arrest concept
fixed dose rate gem - 0 views
-
uses very low dose gem over 6 hrs
TCS_Angio96.pdf (application/pdf Object) - 0 views
-
useful kit not sure about using methodology ourselves
About RNA interference (RNAi) on CGAP - 0 views
-
excellent starting point for siRNA work
h_rhoPathway - 0 views
-
this pathway site is very usefull. this pathway useful for stephen
h_vegfPathway - 0 views
-
good pathway
Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Facto... - 0 views
-
vegfr polmorphims coorelates with survival and avastin use
Does Gefitinib Shorten Lung Cancer Survival? Chaos Redux -- Keedy et al. 26 (15): 2428 ... - 0 views
-
editorial on worsening survival with gefitinib
Rho GTPases and Leukocyte Adhesion Receptor Expression and Function in Endoth... - 0 views
-
rho regulates icam and icam is a biomarker for response to avastin
Redefining the Target: Chemotherapeutics as Antiangiogenics -- Miller et al. 19 (4): 11... - 0 views
The Combination of Epidermal Growth Factor Receptor Inhibitors with Gemcitabine and Rad... - 0 views
fixed dose rate gem - 0 views
‹ Previous
21 - 40
Next ›
Last »
Showing 20▼ items per page
